Bisphosphonates
Bisphosphonates are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) widely used in the treatment of various bone-related conditions. These compounds play a crucial role in inhibiting bone resorption, making them particularly effective in managing diseases such as osteoporosis, Paget's disease, and bone metastasis associated with cancer.
The mechanism of action of bisphosphonates involves their binding to hydroxyapatite crystals in bone, leading to the suppression of osteoclast activity. By inhibiting the breakdown of bone tissue, these APIs help to maintain bone density and strength, thereby reducing the risk of fractures and improving overall bone health.
One of the key advantages of bisphosphonates is their high affinity for bone tissue, which allows for targeted treatment. They are administered orally or intravenously, depending on the specific formulation and indication. Commonly prescribed bisphosphonates include alendronate, ibandronate, and zoledronic acid, among others.
Bisphosphonates are generally well-tolerated, although some potential side effects, such as gastrointestinal disturbances or musculoskeletal pain, may occur. These APIs are metabolized in the liver and excreted through the kidneys.
Due to their effectiveness and widespread clinical use, bisphosphonates have gained significant attention in the pharmaceutical industry. Continuous research and development efforts are focused on improving their therapeutic profiles, including enhancing potency and reducing side effects.
In summary, bisphosphonates are a critical subcategory of pharmaceutical APIs employed in the management of bone-related disorders. Their targeted action on bone tissue and ability to inhibit bone resorption make them indispensable in the treatment of conditions like osteoporosis and bone metastasis. Ongoing advancements in this field are expected to further optimize their therapeutic benefits in the future.
| Name | CAS number | Category | Amount of suppliers |
|---|---|---|---|
| Clodronate | 10596-23-3 | Bisphosphonates | 5 |
| Ibandronate | 114084-78-5 | Bisphosphonates | 16 |
| Pamidronate | 40391-99-9 | Bisphosphonates | 4 |
| Pamidronate disodium pentahydrate | 109552-15-0 | Bisphosphonates | 8 |
| Risedronate | 105462-24-6 | Bisphosphonates | 20 |
| Risedronate sodium | 118-55-8 | Bisphosphonates | 1 |
| Zoledronic Acid Maleate | 118072-93-8 | Bisphosphonates | 34 |
| Zoledronic acid | 329003-65-8 | Bisphosphonates | 4 |